On March 26, the Board of Pharmacy will be holding its regularly scheduled meeting at 9:30 am; virtual participation is available. The Legislative Committee will be meeting immediately prior to the Board meeting and discussing pharmacist’s “right to refuse” and flavoring prescriptions.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
On January 31, the Board of Pharmacy held its regular monthly meeting. The Board continued the following unfinished business from last year:
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
The Board of Pharmacy will be holding its regular meeting on January 17. The agenda includes Pharmacists Dispensing and Administering Contraceptives Regulation Draft Update, Pharmacists Well-Being Index, Board of Pharmacy Act Revisions and Review and Consideration of Pharmacy License Specialties.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
The Department of Health and Social Services presented an online seminar on the state’s unwinding of pandemic plan and its impact on Medicaid recipients. Beginning April 1, 2023, the state will begin requiring renewals from recipients. The impact to pharmacies could be a temporary loss of benefits.
For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.
On December 9, Gov. John Carney (D) extended the Public Health Emergency (PHE) another 30 days permitting medical providers to continue COVID-19 vaccination and testing programs. This is the 10th extension of the PHE.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Office of Controlled Substances announced the 2023 meeting schedule for the Controlled Substance Advisory Committee. Meetings will be held at 9:00 a.m. on January 25, April 26, July 26 and October 25.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
On October 13, Gov. John Carney (D) extended the Public Health Emergency (PHE) another 30 days permitting medical providers to continue COVID-19 vaccination and testing programs. This is the 8th extension of the PHE.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
Governor John Carney (D) signed HB 399 authorizing a pharmacist to order, test, screen and treat certain health conditions pursuant to a statewide written protocol for CLIA-waived tests approved by the Division of Public Health. These health conditions include flu; Strep A; COVID or other respiratory illness, condition or disease; lice; skin conditions including ring worm and athlete’s foot or other emerging and existing public health threats identified and permitted by the Division of Public Health. A pharmacist may also delegate the administration and technical performance of the CLIA-waived test to an intern or pharmacy technician acting under the supervision of the pharmacist.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Office of Controlled Substances Controlled Substance Advisory Committee Meeting scheduled for September 28 is cancelled. The next meeting will be held on November 30 at 9:00 a.m.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
